Reaction Details |
| Report a problem with these data |
Target | Steroidogenic factor 1 |
---|
Ligand | BDBM84342 |
---|
Substrate/Competitor | n/a |
---|
IC50 | >67574±n/a nM |
---|
Citation | PubChem, PC Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput dose response assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay PubChem Bioassay(2013)[AID] |
---|
More Info.: | Get all data from this article |
---|
|
Steroidogenic factor 1 |
---|
Name: | Steroidogenic factor 1 |
Synonyms: | AD4BP | Adrenal 4-binding protein | FTZF1 | Fushi tarazu factor homolog 1 | NR5A1 | Nuclear receptor subfamily 5 group A member 1 | SF-1 | SF1 | STF-1 | STF1_HUMAN | Steroid hormone receptor Ad4BP |
Type: | Nuclear Hormone Receptor |
Mol. Mass.: | 51643.43 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 461 |
Sequence: | MDYSYDEDLDELCPVCGDKVSGYHYGLLTCESCKGFFKRTVQNNKHYTCTESQSCKIDKT
QRKRCPFCRFQKCLTVGMRLEAVRADRMRGGRNKFGPMYKRDRALKQQKKAQIRANGFKL
ETGPPMGVPPPPPPAPDYVLPPSLHGPEPKGLAAGPPAGPLGDFGAPALPMAVPGAHGPL
AGYLYPAFPGRAIKSEYPEPYASPPQPGLPYGYPEPFSGGPNVPELILQLLQLEPDEDQV
RARILGCLQEPTKSRPDQPAAFGLLCRMADQTFISIVDWARRCMVFKELEVADQMTLLQN
CWSELLVFDHIYRQVQHGKEGSILLVTGQEVELTTVATQAGSLLHSLVLRAQELVLQLLA
LQLDRQEFVCLKFIILFSLDLKFLNNHILVKDAQEKANAALLDYTLCHYPHCGDKFQQLL
LCLVEVRALSMQAKEYLYHKHLGNEMPRNNLLIEMLQAKQT
|
|
|
BDBM84342 |
---|
n/a |
---|
Name | BDBM84342 |
Synonyms: | 4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol | 4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol, 1 | 4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol;hydrochloride | 4-[1-hydroxy-2-(methylamino)ethyl]pyrocatechol;hydrochloride | 4-[2-(methylamino)-1-oxidanyl-ethyl]benzene-1,2-diol;hydrochloride | DL-ADRENALINE HYDROCHLORIDE | EPINEPHRINE | EPINEPHRINE,(+) | MLS001333244 | SMR000058236 | cid_5924 |
Type | Small organic molecule |
Emp. Form. | C9H13NO3 |
Mol. Mass. | 183.2044 |
SMILES | CNCC(O)c1ccc(O)c(O)c1 |
Structure |
|